secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2022-05-23T23:59:59+00:00
Accession:  0001171520-22-000319
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro amends director compensation plan; sets retainers and equity grants
--------------------------------------------------------------------------------

- Board chair annual retainer set at $75,000; other members receive $40,000.
- Audit committee chair retainer $20,000; members $10,000; compensation and governance chairs $15,000 and $12,000 respectively.
- New directors receive restricted stock award valued at $90,000 plus options for 2/3 of RSU shares.
- Annual equity grants: each non-employee director gets $90,000 in RSUs plus options (2/3 of RSU count).
- Options vest on first anniversary or day before next annual meeting; exercise price at fair market value on grant date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000319/0001171520-22-000319-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000319/eps10272.htm
  HTML page:      https://secwatch.observer/filing/0001171520-22-000319

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer